| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total non-operating income (expenses), net | 86,206 | 2,779 | ||
| Income (loss) before income taxes | 141,137 | 11,223 | ||
| Income tax expense | 23,864 | 6,376 | ||
| Net income (loss) | 117,273 | 4,847 | ||
| Basic net income (loss) per share (in usd per share) | 5.99 | 0.25 | ||
| Diluted net income (loss) per share (in usd per share) | 5.68 | 0.24 | ||
| Shares used in basic per share calculation (in shares) | 19,578,000 | 19,327,000 | ||
| Shares used in diluted per share calculation (in shares) | 20,629,000 | 19,926,000 | ||
LIGAND PHARMACEUTICALS INC (LGNDZ)
LIGAND PHARMACEUTICALS INC (LGNDZ)